Patents by Inventor Annica Ponten

Annica Ponten has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Platelet-derived growth factor D, DNA coding therefor, and uses thereof
    Publication number: 20070042413
    Abstract: PDGF-D, a new member of the PDGF/VEGF family of polypeptide growth factors, is described, as well as nucleotide sequences encoding, methods for producing, pharmaceutical compositions containing this new growth factor, and its antibodies and other antagonists. Also disclosed are transfected and transformed host cells expressing PDGF-D, and uses thereof in medical and diagnostic applications.
    Type: Application
    Filed: August 22, 2006
    Publication date: February 22, 2007
    Applicants: Ludwig Institute for Cancer Research, Licentia Ltd.
    Inventors: Ulf Eriksson, Karin Aase, Xuri Li, Annica Ponten, Marko Uutela, Kari Alitalo, Arne Oestman, Carl-Henrik Heldin
  • Platelet-derived growth factor D, DNA coding therefor, and uses thereof
    Patent number: 7148037
    Abstract: PDGF-D, a new member of the PDGF/VEGF family of polypeptide growth factors, is described, as well as nucleotide sequences encoding, methods for producing, pharmaceutical compositions containing this new growth factor, and its antibodies and other antagonists. Also disclosed are transfected and transformed host cells expressing PDGF-D, and uses thereof in medical and diagnostic applications.
    Type: Grant
    Filed: March 4, 2002
    Date of Patent: December 12, 2006
    Assignees: Ludwig Institute for Cancer Research, Licentia Ltd.
    Inventors: Ulf Eriksson, Karin Aase, Xuri Li, Annica Ponten, Marko Uutela, Kari Alitalo, Arne Oestman, Carl-Henrik Heldin
  • Non-human transgenic animals expressing platelet-derived growth factor C (PDGF-C) and uses thereof
    Patent number: 7034200
    Abstract: Non-human transgenic animals overexpressing PDGF-C and cells thereof have been created. The transgenic animals contain a nucleotide sequence that encodes for platelet derived growth factor C (PDGF-C) or an analog thereof, or a functional fragment of PDGF-C or analog thereof. These animals are useful for studying disease states characterized by overexpression of PDGF-C, as well as useful for evaluating therapies intended to treat such diseases.
    Type: Grant
    Filed: March 28, 2001
    Date of Patent: April 25, 2006
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Ulf Eriksson, Xuri Li, Annica Ponten, Karin Aase, Hong Li
  • Platelet-derived growth factor D
    Patent number: 6706687
    Abstract: PDGF-D, a new member of the PDGF/VEGF family of growth factors, is described, as well as the nucleotide sequence encoding it, methods for producing it, antibodies and other antagonists to it, transfected and transformed host cells expressing it, pharmaceutical compositions containing it, and uses thereof in medical and diagnostic applications.
    Type: Grant
    Filed: November 10, 1999
    Date of Patent: March 16, 2004
    Assignees: Ludwig Institute for Cancer Research, Helsinki University
    Inventors: Ulf Eriksson, Karin Aase, Xuri Lee, Annica Ponten, Marko Uutela, Kari Alitalo, Arne Oestman, Carl-Henrik Heldin
  • Platelet-derived growth factor C, DNA coding therefor, and uses thereof
    Publication number: 20020164687
    Abstract: PDGF-C, a new member of the PDGF/VEGF family of growth factors, is described, as well as the nucleotide sequence encoding it, methods for producing it, antibodies and other antagonists to it, transfected and transformed host cells expressing it, pharmaceutical compositions containing it, and uses thereof in medical and diagnostic applications.
    Type: Application
    Filed: May 10, 2001
    Publication date: November 7, 2002
    Inventors: Ulf Eriksson, Karin Aase, Xuri Li, Annica Ponten, Marko Uutela, Kari Alitalo, Arne Oestman, Carl-Henrik Heldin, Christer Betsholtz
  • Platelet-derived growth factor D, DNA coding therefor, and uses thereof
    Publication number: 20020164710
    Abstract: PDGF-D, a new member of the PDGF/VEGF family of polypeptide growth factors, is described, as well as nucleotide sequences encoding, methods for producing, pharmaceutical compositions containing this new growth factor, and its antibodies and other antagonists. Also disclosed are transfected and transformed host cells expressing PDGF-D, and uses thereof in medical and diagnostic applications.
    Type: Application
    Filed: March 4, 2002
    Publication date: November 7, 2002
    Inventors: Ulf Eriksson, Karin Aase, Xuri Li, Annica Ponten, Marko Uutela, Kari Alitalo, Arne Oestman, Carl-Henrik Heldin
  • Non-human transgenic animals expressing platelet-derived growth factor C (PDGF-C) and uses thereof
    Publication number: 20020049987
    Abstract: Non-human transgenic animals overexpressing PDGF-C and cells thereof have been created. The transgenic animals contain a nucleotide sequence that encodes for platelet derived growth factor C (PDGF-C) or an analog thereof, or a functional fragment of PDGF-C or analog thereof. These animals are useful for studying disease states characterized by overexpression of PDGF-C, as well as useful for evaluating therapies intended to treat such diseases.
    Type: Application
    Filed: March 28, 2001
    Publication date: April 25, 2002
    Inventors: Ulf Eriksson, Xuri Li, Annica Ponten, Karin Aase, Hong Li